Results 111 to 120 of about 5,067,029 (185)
A Case Report of Response to Quetiapine Treatment in Neuropsychiatric Manifestations of Juvenile Huntington\'s Disease (JHD) [PDF]
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i BābulBackground and Objective: Juvenile Huntington’s disease (JHD) represents a rare form of neurodegenerative genetic disorder characterized by potential neuropsychiatric symptoms.
TMS Tengku Kamarulbahri, F Rahim
doaj
Cognitive decline in Huntington's disease expansion gene carriers
, 2017 In Huntington's Disease (HD) cognitive decline can occur before unequivocal motor signs become apparent. As cognitive decline often starts early in the course of the disease and has a progressive nature over time, cognition can be regarded as a key ...
De Tommaso, Marina +10 more
core +2 more sources
Predicting the Risk of Huntington's Disease with Multiple Longitudinal Biomarkers.
, 2019 BACKGROUND:Huntington's disease (HD) has gradually become a public health threat, and there is a growing interest in developing prognostic models to predict the time for HD diagnosis.
Li, Fan +4 more
core +1 more source
Drug-Resistant Epilepsy in Children with Juvenile Huntington's Disease: A Challenging Case and Brief Review. [PDF]
Qatar Med J, 2020 Khair Md AM, Kabrt DO J, Falchek Md S.
europepmc +1 more source
Somatic CAG Repeat Stability in a Transgenic Sheep Model of Huntington's Disease
Somatic instability of the huntingtin (HTT) CAG repeat mutation modifies age-at-onset of Huntington's disease (HD). Understanding the mechanism and pathogenic consequences of instability may reveal therapeutic targets.
Burch, Zoe +11 more
core +1 more source
The MicrobeThe CRISPR-Cas systems, initially identified as bacterial defense mechanisms, have become innovative tools for genetic research and translational therapeutics. These systems are made up of clustered regularly interspaced short palindromic repeats (CRISPR)
Kamran Saeed +3 more
doaj +1 more source